Endoscopic ultrasound-guided celiac plexus neurolysis in pancreatic cancer: A prospective pilot study of safety using 10 ml versus 20 ml alcohol

Julia K. Leblanc, Susan Rawl, Michelle Juan, Cynthia Johnson, Kurt Kroenke, Lee McHenry, Stuart Sherman, Kathy McGreevy, Mohammad Al-Haddad, John Dewitt

Research output: Contribution to journalArticle

20 Scopus citations


Background. The dose of alcohol used in EUS-CPN is not standardized. The objective was to compare the safety of 20 mL alcohol versus 10 mL alcohol during EUS-CPN for patients with pancreatic cancer-related pain. Methods. 20 patients were selected to receive 10 mL or 20 mL of alcohol during EUS-CPN. Followup was done at baseline, 24 hours, and weekly. Health-related quality of life (HRQoL) was assessed at baseline, week 2, week 4, and every 4 weeks thereafter until pain returned. Results. There were no major complications in both groups. Minor self-limited adverse effects were seen in 6 (30%) subjects and included lightheadedness in 1 (5%), transient diarrhea in 2 (10%), and transient nausea and vomiting in 3. Pain relief was similar in both groups: 80% in the 10 mL group and 100% in the 20 mL group (P=0.21). The mean (± SD) duration of pain relief in the 10 mL and 20 mL groups was 7.9±10.8 and 8.4±9.2 weeks, respectively. 30% of patients in each group had complete pain relief. Conclusions. EUS-CPN using 20 mL of alcohol is safe. Similar clinical outcomes were seen in both groups. Further investigations to confirm these findings are warranted.

Original languageEnglish (US)
Article number327036
JournalDiagnostic and Therapeutic Endoscopy
StatePublished - Feb 11 2013


ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this